Current through Register Vol. 50, No. 9, September 20, 2024
A. No
bleeder medication may be administered to a horse in training for a race during
any race meeting except upon compliance with the following.
1. Only a licensed veterinarian may
prescribe, dispense and administer bleeder medication.
2. No horse entered to race may be
administered bleeder medication within four hours of post-time of the race in
which the horse is to run.
B. A horse shall be considered a known
bleeder when:
1. it is observed bleeding by a
commission veterinarian during and/or after a race or workout;
2. an endoscopic examination authorized by
the commission veterinarian or state steward, conducted within one hour of a
race or workout, reveals blood in the trachea and/or upper respiratory tract of
the horse examined;
3. a statement
from a commission or association veterinarian of any other racing jurisdiction,
confirming that a specific horse is a known bleeder is received by the
commission or stewards having jurisdiction of the race meeting where such horse
may be eligible to race.
C. A horse may be removed from the bleeder
list only upon the direction of a commission veterinarian, who shall certify in
writing to the stewards the recommendation for removal.
D. The commission veterinarian at each race
meeting shall maintain a current list of all horses, which have demonstrated
external evidence of exercise induced pulmonary hemorrhage from one or both
nostrils during or after a race or workout as observed by the commission
veterinarian.
E. A bleeder,
regardless of age, shall be placed on the bleeder list and be ineligible to run
during the following periods of time:
1. first
time, for 14 days;
2. second time,
within a 365 day period, for 30 days;
3. third time, within 365 day period, for 180
days;
4. fourth time, within a 365
day period, lifetime suspension;
5.
should a horse which is on the bleeder list race three times within 365 days
without bleeding, it shall be considered a first-time bleeder when next it is
observed bleeding by a commission veterinarian or an endoscopic examination,
conducted within one hour of a race, reveals blood in the trachea and/or upper
respiratory tract;
6. for the
purposes of this rule the period of ineligibility on the first day bleeding was
observed;
7. the voluntary
administration of bleeder medication without evidence of an external bleeding
incident does not subject a horse to the above periods of
ineligibility.
F. The
licensed veterinarian prescribing, dispensing, and administering bleeder
medication must furnish a written report to the commission veterinarian at
least one hour prior to post-time for the first race of the day on forms
supplied by the commission. Furnishing of such written report timely shall be
the responsibility of the prescribing, dispensing, and/or administering
veterinarian. The following information shall be provided, under oath, on a
form provided by the commission:
1. the name
of the horse, racetrack name, the date and time the permitted bleeder
medication was administered to the entered horse;
2. the dosage amount of bleeder medication
administered to the entered horse; and
3. the printed name and signature of the
licensed veterinarian who administered the bleeder medication.
G. Approved bleeder medication may
be voluntarily administered intravenously to a horse, which is entered to
compete in a race subject to compliance with the following conditions:
1. the trainer and/or attending veterinarian
determine it is in a horse's best interests to race with bleeder medication,
and they make written request upon the commission veterinarian, using the
prescribed form, that the horse to be placed on the voluntary bleeder
medication list;
2. the request is
actually received by the commission veterinarian or his/her designee by the
time of entry;
3. the horse race
with bleeder medication and remain on the voluntary bleeder medication list
unless and until the trainer and attending veterinarian make a joint, written
request on a form provided by the commission to the commission veterinarian to
remove the horse from the list;
4.
once removed from the voluntary bleeder medication list, a horse may not be
voluntarily placed back on the list for a period of 60 days unless the
commission veterinarian determines on recommendation and concurrence of the
attending veterinarian that it jeopardizes the welfare of the horse. Once a
horse is voluntarily removed from the list twice within a 365-day period, the
horse may not be voluntarily placed back on the list for bleeder medication for
a period of 90 days.
H.
In order to insure that the use of bleeder medication is reported accurately,
the commission shall have the right to perform or have performed testing of
blood or urine of any horse eligible to race at a meeting, whenever it is
deemed necessary by it or its stewards. The veterinarian administering the
approved bleeder medication shall surrender the syringe used to administer such
medication for testing upon request of the commission veterinarian, a steward
or either of their designated representatives.
I. Post race analysis of furosemide must show
detectable concentrations of the drug in serum, plasma or urine sample that is
indicative of appropriate administration.
1.
Specific gravity of post-race urine samples may be measured to ensure that
samples are sufficiently concentrated for proper chemical analysis. Specific
gravity shall not be below 1.010. If the specific gravity of the urine is below
1.010 or a urine sample is unavailable for testing, quanitation of furosemide
shall be performed in serum or plasma.
2. Quanitation of furosemide in serum or
plasma may not exceed 100 nanograms of furosemide per milliliter of serum or
plasma.
AUTHORITY NOTE:
Promulgated in accordance with
R.S.
4:141 and
R.S.
4:142.
